As SUCLG2 depletion‐mediated mitochondrial dysfunction contributed to LUAD inhibition, we hypothesized that the downregulation of SUCLG2 might be a potentially feasible strategy to block tumor growth. Here, SUCLG2 is linked to neoplasm.